Breast Implant Patient Follow-Up Data Collection Crucial – FDA Guidance
This article was originally published in The Gray Sheet
Executive Summary
Breast implant manufacturers should offer incentives in order to encourage patient cooperation with post-implant study data collection efforts, FDA advises in a final guidance document